Voriconazole Intravenous (Iv) Solution Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Solution

Available Strengths: 200 mg/100 mL

Reference Brands: Vfend(US & EU)

Category: Anti-fungal

Voriconazole Intravenous (IV) Solution is available in Intravenous (IV) Solution and strengths such as 200 mg/100 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Voriconazole Intravenous (IV) Solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Voriconazole Intravenous (IV) Solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Voriconazole IV solution is approved in the EU and US for severe fungal infections. In the EU, Pfizer’s Vfend IV is regulated by EMA, backed by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with regulatory dossiers, submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We support efficient market access for voriconazole IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.